AD is characterized by the extracellular accumulation of amyloid-β peptide (Aβ) aggregates and filamentous intraneuronal inclusions of hyperphosphorylated tau protein (p-tau), which culminates in synaptic dysfunction and neuronal loss. This evidence concerns the gene MAPT and Alzheimer disease.